Sei Investments Co. Cuts Stock Position in Privia Health Group, Inc. $PRVA

Sei Investments Co. cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 69.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 140,370 shares of the company’s stock after selling 320,283 shares during the quarter. Sei Investments Co. owned 0.11% of Privia Health Group worth $2,887,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bayban purchased a new position in Privia Health Group during the 4th quarter worth $26,000. Hantz Financial Services Inc. increased its stake in shares of Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after acquiring an additional 926 shares during the period. Global Retirement Partners LLC raised its holdings in Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after purchasing an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board raised its holdings in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new stake in Privia Health Group in the fourth quarter valued at about $93,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Privia Health Group

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia reported second-quarter revenue of $632.6 million, up 21.4% year over year and above the approximately $597.3 million consensus. Net income rose to $9.0 million from $2.7 million, while adjusted EBITDA increased 29.1% to $37.4 million. Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
• Positive Sentiment: Management raised or improved its full-year 2026 expectations across key operating metrics, including attributed lives, practice collections, GAAP revenue, care margin, platform contribution and adjusted EBITDA. Revenue is expected toward the high end of the $2.35 billion-$2.45 billion range, with adjusted EBITDA of $145 million-$155 million. Privia Health Raises 2026 Outlook
• Positive Sentiment: Underlying growth indicators remained strong: implemented providers rose 10.1% to 5,644, value-based-care attributed lives increased 19.2% to 1.647 million, and the adjusted EBITDA margin expanded to 28.3% from 25.2%. Privia Health Q2 2026 Earnings Presentation
• Neutral Sentiment: Zacks upgraded PRVA from “strong sell” to “hold,” signaling reduced downside expectations but not a bullish recommendation. Zacks
• Negative Sentiment: GAAP EPS was $0.07, narrowly below Zacks’ $0.08 estimate. Reported profitability also included $19.4 million of non-cash stock-based compensation, while operating cash flow was negative $48.4 million in the first half, factors that may temper enthusiasm over earnings quality. Privia Health Misses Q2 Earnings Estimates

Insider Buying and Selling

In other Privia Health Group news, CEO Parth Mehrotra sold 105,439 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $22.55, for a total transaction of $2,377,649.45. Following the completion of the transaction, the chief executive officer owned 450,004 shares of the company’s stock, valued at approximately $10,147,590.20. This trade represents a 18.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Matthew Shawn Morris sold 88,110 shares of the business’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $25.33, for a total value of $2,231,826.30. Following the completion of the transaction, the director directly owned 76,651 shares of the company’s stock, valued at approximately $1,941,569.83. This trade represents a 53.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 452,357 shares of company stock worth $11,436,655 in the last ninety days. Insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on PRVA. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday. Canaccord Genuity Group set a $32.00 price target on Privia Health Group in a research note on Friday. Barclays dropped their price objective on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Citigroup reiterated a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Finally, Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $31.00.

Privia Health Group Price Performance

PRVA stock opened at $22.45 on Friday. The company’s 50 day simple moving average is $24.63 and its 200-day simple moving average is $23.35. The firm has a market capitalization of $2.83 billion, a PE ratio of 106.91, a P/E/G ratio of 1.74 and a beta of 0.85. Privia Health Group, Inc. has a 12 month low of $19.53 and a 12 month high of $28.82.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.